SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes

By sjmartinez • January 13, 2025

Bhatti AW, Patel R, Dani SS, Khadke S, Makwana B, Lessey C, Shah J, Al-Husami Z, Yang EH, Thavendiranathan P, Neilan TG, Sadler D, Cheng RK, Dent SF, Liu J, Lopez-Fernandez T, Herrmann J, Scherrer-Crosbie M, Lenihan DJ, Hayek SS, Ky B, Deswal A, Barac A, Nohria A, Ganatra S. SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes. JACC CardioOncol. 2024 Sep 22;6(6):863-875. doi: 10.1016/j.jaccao.2024.08.001. PMID: 39801650; PMCID: PMC11711834.

Tags: antineoplastic therapy, Cardiology/Epi, cardiomyopathy, CTRCD, primary prevention, Publications, sodium glucose co-transporter 2 inhibitors

Get With the Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead

Tang AB, Lewsey SC, Yancy CW, Heidenreich PA, Greene SJ, Allen LA, Jessup M, Bolles M, Rutan C, Navar N, Thomas K, Fonarow GC. Get[...]

Anhedonia Symptoms and High Sensitivity C-Reactive Protein (hs-CRP) Several Years Postpartum

Nicoloro-SantaBarbara JM, Carroll JE, Minissian M, Kilpatrick SJ, Merz CNB, Accortt EE. Anhedonia Symptoms and High Sensitivity C-Reactive Protein (hs-CRP) Several Years Postpartum. Am J[...]

Comparative Prognostic Value of Risk Factors for Predicting Pacemaker Implantation After Transcatheter Aortic Valve Replacement: A Systematic Review and Network Meta-analysis

Mohammadi NSH, Tavakoli K, Taebi M, Zafari A, Riahi M, Molaei MM, Farooqi MA, Khanipour R, Karvane HB, Shahrzad S, Vaseghi M, Lakkirrddy GR, Mattumpuram[...]